| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/21/1999 | WO1999002694A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 01/21/1999 | WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | WO1999002170A1 Absorption of minerals by intestinal cells |
| 01/21/1999 | WO1999002169A1 Method for producing virus-inactivated blood plasma or blood serum in lyophilised form |
| 01/21/1999 | WO1998046781A3 Novel transgene expression system for increased persistence |
| 01/21/1999 | DE19729778A1 Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten A process for the production of virus-inactivated biological fluids |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892045A2 Process for the production of a preparation containing hyaluronidase |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891777A1 Fango containing pack and process for producing the same |
| 01/20/1999 | EP0891419A1 Hematopoietic cell culture nutrient supplement |
| 01/20/1999 | EP0891241A1 Guard and control apparatuses for sliding compound miter saw |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205737A Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof |
| 01/20/1999 | CN1205213A Health products able to suppress tumour cell |
| 01/20/1999 | CN1205208A Leech essence |
| 01/20/1999 | CN1205187A Canned turtle |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861313 Method of isolating bile duct progenitor cells |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same |
| 01/19/1999 | US5861177 Spherical pancreatin particles free from added binder, free of 30-50 micrometer diameter particles; retain activity, made by treating before solvents are removed |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861158 Improving a transplantation of hematopoietic cells from a donor to a recipient |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | CA2215339C Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/19/1999 | CA2081703C Thrombin and method of producing the same |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/14/1999 | WO1999001198A1 Blood processing chamber counter-balanced with blood-free liquid |
| 01/14/1999 | WO1999001197A1 Systems and methods for collecting diluted mononuclear cells |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001163A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | WO1999001159A1 Lineage-restricted neuronal precursors |
| 01/14/1999 | WO1999001147A1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis |
| 01/14/1999 | WO1999001146A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | WO1999001124A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/14/1999 | WO1999001034A1 Method for producing new hair growth |
| 01/14/1999 | WO1998044096A3 Mycobacterium recombinant vaccines |
| 01/14/1999 | WO1998039466A3 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2294916A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | CA2294737A1 Lineage-restricted neuronal precursors |
| 01/14/1999 | CA2294395A1 Systems and methods for collecting diluted mononuclear cells |
| 01/14/1999 | CA2294307A1 Blood processing chamber counter-balanced with blood-free liquid |
| 01/14/1999 | CA2264792A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890637A1 Method of reconstructing animal organs |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | EP0889729A1 Linseed drug |
| 01/13/1999 | EP0889721A1 Remedy for external application, and use of an oil-in-water emulsion for said remedy |
| 01/13/1999 | EP0775005A4 Blood processing systems controlled by apparent hematocrit |
| 01/13/1999 | EP0750664A4 Reproduction and utilization of functional human tissue |
| 01/13/1999 | EP0671910A4 Glaucoma treatment. |
| 01/13/1999 | CN1205033A Method for obtaining microorganism capable of producing antibumor molecules |
| 01/13/1999 | CN1204533A Medicine for treatment of mammary gland disease and method for producing thereof |
| 01/13/1999 | CN1204528A Medcinal composition for treatment of myopia, amblyopia and preparation method thereof |
| 01/13/1999 | CN1204526A 'Huweiling' capsule- for protecting stomach |
| 01/13/1999 | CN1204520A Medicine for treatment of lithiasis |
| 01/13/1999 | CN1204519A Health-care wine |
| 01/13/1999 | CN1204515A Chinese medicinal preparation for treatment of toothache and method for preparation thereof |
| 01/13/1999 | CN1041602C Method for prepn. of 'Tiancheng Jinzhi' nutritious liquor |
| 01/13/1999 | CN1041601C Traditional Chinese medicine for treating migraine |
| 01/12/1999 | US5859226 Nucleotide sequences which suppress immune response by reducing major histocompatibility/human leukocyte antigen gene expression; for transplantation, autoimmune diseases, hepatitis b and cytomegalovirus infections |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5858991 Administering a polysaccharide toxin to reduce scarring and to provide reduced vessel density at the site of the wound |
| 01/12/1999 | US5858983 Inhibiting binding of cell bearing selectin protein to molecule or cell bearing sialyl-lewis x determinant by contacting with antibody bearing said determinant |
| 01/12/1999 | US5858963 Inducing xenograft tolerance and porcine cytokines therefor |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858782 Functional human hematopoietic cells |
| 01/12/1999 | US5858775 Adeno-associated virus materials and methods |
| 01/12/1999 | US5858746 Addition polymerization of a water-soluble macromolecular monamer to coat, support, microencapsulate, plug, adhere cells, cell aggregates or tissue |
| 01/12/1999 | US5858744 Gene transfer into stem cells |
| 01/12/1999 | US5858743 Delivery of nucleic acids |
| 01/12/1999 | US5858740 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/12/1999 | US5858727 Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms |
| 01/12/1999 | US5858721 Three-dimensional cell and tissue culture system |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858701 DNA encoding an insulin receptor substrate |
| 01/12/1999 | US5858643 Red blood cell composition containing vitamin E or derivatives thereof which exhibits reduced potassium ion leakage after a photoinactivation process |
| 01/12/1999 | US5858641 Passing blood through polymer filter prior to transfusions; use of dyes and filter enable long term storage without bacterial, viral or parasite contamination |
| 01/12/1999 | US5858400 Co-administering an agent having large liposomes that include phospholipids substantially free of sterol |
| 01/12/1999 | US5858390 Preparation of cultured undifferentiated mesenchymal cells and injection of the cell preparation |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |